[go: up one dir, main page]

CR8480A - Formulaciones veterinarias que contienen producto no animal - Google Patents

Formulaciones veterinarias que contienen producto no animal

Info

Publication number
CR8480A
CR8480A CR8480A CR8480A CR8480A CR 8480 A CR8480 A CR 8480A CR 8480 A CR8480 A CR 8480A CR 8480 A CR8480 A CR 8480A CR 8480 A CR8480 A CR 8480A
Authority
CR
Costa Rica
Prior art keywords
animal product
formulations containing
animal
containing non
binder
Prior art date
Application number
CR8480A
Other languages
English (en)
Inventor
Cleverly Douglas
Hagenbuch Michelle
Chen Jun
Azad Abul
Muhitch James
Chen Wen-Hsia
Nached Hassan
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of CR8480A publication Critical patent/CR8480A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invencion proporciona una formulacion veterinaria masticable que no contiene productos animales, que comprende: una cantidad efectiva de un agente farmaceuticamente activo que comprende ya sea: a) por lo menos un acido de nodulisporamida o derivado de acido nodulisporico; o b) una combiancion que comprende i) por lo menos un derivado de avermectin o milbemicin; y i) por lo menos un compuesto seleccionado del grupo que consiste de prazicuantel y pirantel; por lo menos un aglutinante; por lo menos un desintegrante; por lo menos un producto no animal que contiene sabor o sabor derivado de una fuente no animal; por lo menos un aglutinante; por lo menos un humectante; por lo menos un solvente de granualcion; y opcionalmente, por lo menos un antioxidante, por lo menos un agente regulador del pH, por lo menos un conservador o por lo menos un colorante.
CR8480A 2003-12-23 2006-06-22 Formulaciones veterinarias que contienen producto no animal CR8480A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/745,784 US20040151759A1 (en) 2002-08-16 2003-12-23 Non-animal product containing veterinary formulations

Publications (1)

Publication Number Publication Date
CR8480A true CR8480A (es) 2007-04-24

Family

ID=34739059

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8480A CR8480A (es) 2003-12-23 2006-06-22 Formulaciones veterinarias que contienen producto no animal

Country Status (9)

Country Link
US (1) US20040151759A1 (es)
EP (1) EP1702056A4 (es)
JP (1) JP2007516285A (es)
KR (1) KR20060126728A (es)
CN (1) CN1972672A (es)
AU (1) AU2004308284A1 (es)
BR (1) BRPI0418098A (es)
CR (1) CR8480A (es)
WO (1) WO2005062782A2 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7976884B2 (en) * 2003-08-01 2011-07-12 Nestec Ltd. Edible animal chew toy
NZ529177A (en) * 2003-10-24 2005-12-23 Agres Ltd Administration process for a delivery device that releases the active agent over several days
WO2006036624A2 (en) * 2004-09-24 2006-04-06 The Hartz Mountain Corporation Lipid stabilized formulations
JP4297042B2 (ja) * 2004-11-30 2009-07-15 ブラザー工業株式会社 シート材収納カセット及びそれを備える画像形成装置
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
AU2006203347C1 (en) * 2006-05-15 2009-11-05 Wyeth Stabilised formulation
WO2008003050A2 (en) * 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
EP2101736A4 (en) * 2006-12-19 2012-09-19 Merial Ltd HOMOGENEOUS PULP AND GEL PREPARATIONS
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
JP5319691B2 (ja) * 2007-11-15 2013-10-16 ノバルティス アーゲー プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト
FR2924944A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
AU2008360070B2 (en) * 2008-07-29 2015-04-30 Bomac Research Limited Tablet manufacturing method
AR079409A1 (es) * 2009-09-07 2012-01-25 Mukhopadhyay Debashis Preparaciones antihelminticas granuladas y sistemas de suninistros
AU2011315555B2 (en) * 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
AU2012307656B2 (en) * 2011-09-15 2016-07-07 Friulchem Spa Compositions for oral administration to animals, production methods thereof and uses of same
EP2594258B1 (en) * 2011-11-18 2020-03-18 Veterinärmedizinische Universität Wien Oral gel comprising praziquantel
ME03389B (me) 2012-02-06 2020-01-20 Boehringer Lngelheim Animal Health Usa Lnc Paraziticidne oralne veterinarske kompozicije које sadrže sistemski-delujuća aktivna sredstva, metodi i primene isтih
US20150057321A1 (en) 2012-04-04 2015-02-26 Intervet Inc. Soft chewable pharmaceutical products
KR101348687B1 (ko) * 2012-05-03 2014-01-16 남원모 사료첨가용 은나노 조성물
BR112015023435B1 (pt) 2013-03-15 2022-05-03 Douglas Robert Cleverly Formulação mastigável estável sob armazenagem e método de fabricação de uma formulação mastigável, palatável e estável sob armazenagem
CN103993061B (zh) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 一种鱼胶原蛋白的生产方法
BR112017024773A2 (pt) 2015-05-20 2018-11-06 Merial, Inc. compostos depsipeptídeos anti-helmínticos
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
EP3496714A4 (en) 2016-08-11 2020-04-22 Adamis Pharmaceuticals Corporation DRUG COMPOSITIONS.
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
MX392727B (es) 2016-12-09 2025-03-24 Bayer Animal Health Gmbh Preparación framaceútica de estructura multicapa y método para su fabricación
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
SG11202012922VA (en) 2018-07-09 2021-01-28 Boehringer Ingelheim Animal Health Usa Inc Anthelminthic heterocyclic compounds
WO2020112374A1 (en) 2018-11-20 2020-06-04 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
CN113134008B (zh) * 2020-01-17 2022-08-30 中国农业大学 宠物用伊维菌素吡喹酮咀嚼片及其制备方法
CR20220665A (es) 2020-05-29 2023-07-19 Boehringer Ingelheim Pharma Compuestos heterocíclicos como anthelmínticos
CN116507327A (zh) * 2020-09-03 2023-07-28 礼蓝动物保健有限公司 可咀嚼调配物
WO2022133420A1 (en) 2020-12-18 2022-06-23 Boehringer Ingelheim Animal Health USA Inc. Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof
EP4507694A1 (en) 2022-04-15 2025-02-19 KRKA, d.d., Novo mesto Soft chewable veterinary dosage form
CN120361008B (zh) * 2025-04-28 2025-12-09 广州白云山宝神动物保健品有限公司 基于米尔贝肟吡喹酮的寄生虫驱除药物及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615728A (en) * 1968-10-11 1971-10-26 Us Agriculture Method for imparting hickory smoke color and flavor to dried yeast and other food powders
US3773525A (en) * 1970-08-31 1973-11-20 A Pittet Flavoring with bicyclic dehydropiperazines
ZA741203B (en) * 1973-03-23 1975-01-29 Smithkline Corp Veterinary feed compositions for inhibiting rumen microbial deamination
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5180720A (en) * 1991-05-03 1993-01-19 G. D. Searle & Co. 2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
EP0587744B1 (en) * 1991-05-28 2003-07-16 McNEIL-PPC, Inc. Chewable drug-delivery composition
US5477815A (en) * 1992-08-20 1995-12-26 Booda Products, Inc. Dog chew toy
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
US5785382A (en) * 1994-02-16 1998-07-28 Bettacare Limited Infant car seats
US5894029A (en) * 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
ES2167436T3 (es) * 1994-05-20 2002-05-16 Janssen Pharmaceutica Nv Tabletas de flubendazol masticables para animales de compañia.
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US6221894B1 (en) * 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) * 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
CA2178686A1 (en) * 1995-06-13 1996-12-14 Leslie G. Humber Oral formulations of s(+)-etodolac
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6086940A (en) * 1996-10-25 2000-07-11 T.F.H. Publications, Inc. High starch content dog chew
US5827565A (en) * 1996-10-25 1998-10-27 T.F.H. Publications, Inc. Process for making an edible dog chew
US6093427A (en) * 1997-09-03 2000-07-25 T.F.H.Publications, Inc. Vegetable-based dog chew
US6200616B1 (en) * 1996-10-25 2001-03-13 Tfh Publications, Inc. Animal chew
US6126978A (en) * 1996-10-25 2000-10-03 T.F.H. Publications, Inc. Edible dog chew
US6110521A (en) * 1996-10-25 2000-08-29 T.F.H. Publications, Inc. Wheat and casein dog chew with modifiable texture
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6093441A (en) * 1998-07-15 2000-07-25 Tfh Publications, Inc. Heat modifiable peanut dog chew
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6159516A (en) * 1999-01-08 2000-12-12 Tfh Publication, Inc. Method of molding edible starch
US6274182B1 (en) * 1999-11-19 2001-08-14 Tfh Publications, Inc. Animal chew
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
US6399786B1 (en) * 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
DK1197215T3 (da) * 2000-10-10 2006-07-10 Wyeth Corp Anthelmintiske sammensætninger
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
US6787642B2 (en) * 2001-03-23 2004-09-07 The Regents Of The University Of California Use of insect cell membrane transporters as novel target sites for inspection
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
BRPI0418098A (pt) 2007-04-17
EP1702056A2 (en) 2006-09-20
WO2005062782A3 (en) 2006-08-10
CN1972672A (zh) 2007-05-30
EP1702056A4 (en) 2012-05-02
US20040151759A1 (en) 2004-08-05
JP2007516285A (ja) 2007-06-21
AU2004308284A1 (en) 2005-07-14
WO2005062782A2 (en) 2005-07-14
KR20060126728A (ko) 2006-12-08

Similar Documents

Publication Publication Date Title
CR8480A (es) Formulaciones veterinarias que contienen producto no animal
DE60020716D1 (de) Filmbildende zusammensetzungen aus pullulan
CY1117477T1 (el) Κτηνιατρικες μορφοποιησεις που δεν περιεχουν ζωϊκο προϊον
NZ763636A (en) Prolonged ectoparasite-controlling agent for animal
WO2009087474A3 (en) Agonists for antimicrobial peptide systems
MX2010005685A (es) Sistemas de solventes para formulaciones de vaciado determinado para combatir parasitos.
HU229493B1 (en) Antiparasitic formulations
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
PA8541401A1 (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
CY1111923T1 (el) Παρασιτοκτονα σκευασματα
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
GB2386066A (en) Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
JP2016175936A5 (es)
WO2003028475A1 (en) Feeds and fertilizers containing pentacyclic triterpenes
AR036357A1 (es) Composicion de gel endoparasiticida, un metodo para su preparacion y el uso de dicha composición para la manufactura de un medicamento.
ECSP034915A (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
BRPI0415392A (pt) composição agroquìmica fungicida, processo para a preparação da mesma, uso de polilisina, derivados de polilisina ou uma combinação de polilisina e derivados de polilisina, processo para o combate de fungos fitopatogênicos, semente,e, material
WO2009103901A3 (fr) Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
WO2008077130A3 (en) Homogeneous paste and gel formulations
ZA202007060B (en) Solid formulation of insecticidal mixtures
AR030378A1 (es) Empleo de triazintrion-sulfonas para la lucha contra la coccidiosis
CR10319A (es) Formulaciones precisas derivadas de acido nodulisporico para combatir parasitos
WO2002023985A3 (de) Wirkstoffkombinationen zum schutz von tierischen häuten und von leder
PE20050443A1 (es) Formulaciones farmaceuticas transdermicas
WO2005023175A3 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)